Sale!

Pharmacological and Psychosocial Treatments in Schizophrenia 3rd Edition by David Castle, David L Copolov, Til Wykes, Kim T Mueser ISBN 1842145347 9781842145340

Original price was: $50.00.Current price is: $35.00.

Pharmacological and Psychosocial Treatments in Schizophrenia Third Edition David Castle Digital Instant Download

Author(s): David Castle, David L. Copolov, Til Wykes, Kim T. Mueser
ISBN(s): 9781842145340, 1842145347
Edition: 3
File Details: PDF, 1.81 MB
Year: 2012
Language: english
SKU: EB-5086226 Category: Tags: , , ,

Pharmacological and Psychosocial Treatments in Schizophrenia 3rd Edition by David Castle, David L Copolov, Til Wykes, Kim T Mueser – Ebook PDF Instant Download/Delivery: 1842145347, 9781842145340
Full download Pharmacological and Psychosocial Treatments in Schizophrenia 3rd Edition after payment

Product details:

ISBN 10: 1842145347
ISBN 13: 9781842145340
Author: David Castle, David L Copolov, Til Wykes, Kim T Mueser

Pharmacological and Psychosocial Treatments in Schizophrenia provides a succinct clinical overview of key areas pertinent to the holistic treatment of people with schizophrenia and, in particular, puts firmly back onto the agenda the importance of psychosocial treatments. The latest data concerning the newer antipsychotic agents and clinical guidelines for their use are reviewed. The real emphasis, however, is on the psychosocial interventions for specific aspects of schizophrenia symptomatology and disability that have been shown to offer major benefits to recovery in the disorder, and yet have failed to have a high profile in the literature, as more effective biological treatments have become available. This book offers practical guidance on effective strategies for use in both clinical settings and in the family context, placing the patient (and their family) once again at the centre of therapeutic endeavours. Encouraging professionals to offer a broader therapeutic approach, this book will offer real hope to therapists, patients and families of what can be achieved if psychosocial interventions complement the many psychopharmacological treatments available today. Key topics include: female patients, treatment resistance, the substance abuser patient, family intervention, helping the patient at work, managing violent behaviour, first episode psychosis and rating scales in schizophrenia.

Pharmacological and Psychosocial Treatments in Schizophrenia 3rd Table of contents:

1. Psychopharmacological management of schizophrenia
Historical background
Typical antipsychotics
Atypical antipsychotics
Treatment approaches to early episode psychosis
Treatment of relapse of psychosis
Treatment resistance and the place of clozapine
Augmentation strategies
Switching antipsychotics
The place of depot antipsychotics
Complications of antipsychotic treatment and how to deal with them
Conclusions
References

2. Psychological approaches to the management of persistent delusions and hallucinations
Psychological approaches to the reduction of hallucinations
Psychological interventions for delusions
Cognitive–behavioral therapy
What are the outcomes from CBT?
Can we improve the outcome of CBT?
A note about psychological treatments
Resources
Manuals outlining CBT for psychosis
Clinical casebooks of CBT for psychosis
Self-Help resources
Useful websites
References

3. The management of negative symptoms
Diagnosis before treatment
The management of negative symptoms
The prevention and management of secondary negative symptoms
The treatment of primary negative symptoms
Psychosocial aspects of managing negative symptoms
Negative symptoms and family members
Conclusions
References

4. Cognitive dysfunction in schizophrenia
What cognitive systems are disturbed in schizophrenia?
What are the effects of cognitive difficulties on symptoms, rehabilitation, and life skills?
Symptoms
Rehabilitation
Life skills
Treatment issues
Pharmacological approaches to improving cognition in schizophrenia
Psychological approaches
Directly changing cognition
Changing rehabilitation programs to fit strengths
Changing the environment
Conclusions
References

5. Depression and anxiety in schizophrenia
Depression and schizophrenia
Effect of depression on the longitudinal course of schizophrenia
Recognizing depression in schizophrenia
Do antipsychotics cause depression?
Treating depression in schizophrenia
Psychological strategies
Pharmacological strategies
Anxiety disorders in schizophrenia
Social anxiety disorder
Obsessive–compulsive disorder
Treatment of OCD in schizophrenia
Conclusions
References

6. The general health of people with schizophrenia
Medical causes of excess mortality in schizophrenia
Cardiovascular disease
Diabetes Mellitus
Infectious disease
Cancer
Pulmonary Disease
Modifiable risk factors in people with schizophrenia
Obesity
Hypertension
Dyslipidemia
Insulin resistance and hyperglycemia
Metabolic syndrome
Smoking and substance abuse
Primary and secondary prevention
Conclusions
References

7. Substance abuse comorbidity in schizophrenia
Prevalence
Impact on the course of schizophrenia
Clinical implications
Motivations for use
Treatments for substance abuse in psychosis
Psychosocial treatments
Pharmacological strategies
Conclusions
References

8. Management of acute behavioral disturbance in psychosis
“Organic” causes of acute behavioral disturbance
Acute behavioral disturbance in psychosis
Signs of behavioral disturbance
Managing acute behavioral disturbance: nonpharmacological strategies
Managing acute behavioral disturbance: pharmacological strategies
Oral agents
Parenteral agents
An algorithmic approach to pharmacological management of acute behavioral disturbance in psychosis
The role of zuclopenthixol (clopixol) acuphase
Conclusions
Acknowledgements
References

9. Managing the violent behaviors associated with the schizophrenic syndrome
What mediates between the schizophrenic syndrome and violent behavior?
Substance abuse
Active symptoms
Consequences of the psychopathology of schizophrenia
Developmental factors
Current social context
Personality factors
What is to be done?
Culture change in generic services
The assessment of risk
General principles of management
Social interventions
Psychological management
Pharmacological management
Substance abuse
Restructuring therapeutic goals and service systems
On how not to confront violence in inpatient settings
Conclusions
References

10. Understanding and enhancing adherence to treatment in people with schizophrenia
Definitions
Factors affecting adherence
Insight
Reactance
Stigma
Promoting adherence
References

11. Psychological interventions to help people with psychiatric disabilities succeed at work
Work behavior feedback groups with goal setting
The indianapolis vocational intervention program: A cognitive–behavioral approach
Workplace fundamentals: A social skills approach
Neurocognitive enhancement therapy: A cognitive remediation approach
Conclusions
References

12. Enhancing socialization in people with schizophrenia
The development of the social skills training movement in schizophrenia
The efficacy of social skills training in schizophrenia
Improving social skills in the community
The complexity of enhancing socialization in schizophrenia
Environmental factors
Personal factors
Enhancing socialization in recovery-oriented care
Social cognition interventions
Networking through social media
Conclusions
References

13. The clinical needs of women with schizophrenia
Development of schizophrenia in women
Epidemiology of gender differences in schizophrenia
The estrogen protection hypothesis
Basic science evidence for estrogen as a psychoprotectant
Clinical support for the estrogen protection hypothesis
Management of schizophrenia in women
Sexuality and women with schizophrenia
Pregnancy and schizophrenia
Menopause and women with schizophrenia
Medication treatment for women with schizophrenia
Extrapyramidal side effects of antipsychotics in women
Clinical trials
Antipsychotic drug metabolism in women
Hyperprolactinemia
Weight gain and diabetes
Treatment of affective symptoms
Psychological treatments for women with schizophrenia
Service provision for women with schizophrenia
Longer–term outcomes
Conclusions
References

14. Schizophrenia in later life
Epidemiology and risk factors
Symptoms
Positive Symptoms
Disorganization
Negative symptoms
Cognitive symptoms
Management
Pharmacological management
Conclusions
References

15. Family interventions in schizophrenia
Background to family interventions in schizophrenia
Family intervention studies
Modifications to family interventions
First-episode families
Substance use and psychosis
Group family work
Results from the studies
Dissemination of family interventions
Conclusions
References

16. Models of care in schizophrenia
Evolution of the CMHT
Assertive community treatment and the era of mental health services research
Drawing more generalizable principles for service models
What does not help?
Continuity of care vs specialization
Size and composition of CMHTs
Managing caseloads
Assessments and reviews
Team meetings
The future
References

17. A treatment approach to the patient with first-episode schizophrenia
Clinical assessment
Initial management: Antipsychotic drugs
Antipsychotics in practice
Acute agitation
Psychosocial and family interventions
Management of initial uncertainty
Course and further treatment
Treating depression and anxiety
Settings and services
Conclusions
References

18. Treatment-resistant schizophrenia
Seven clinical tools for managing treatment-resistant schizophrenia
Medication algorithms
Neuropsychological therapy and environmental engineering
Contingency management
CBT for treatment-resistant psychotic symptoms
Systematic, expanded, and individualized assessment of psychopharmacotherapy
Therapeutic jurisprudence
Risk assessment and risk management
Treatment resistance, dissemination, and mental health policy
Conclusions
References

19. Rating scales in schizophrenia: Clinical applicability
Rating scales assessing symptoms, needs, strengths, skills, and deficits
Symptoms
– Brief Symptom Inventory
– The Behavior and Symptom Identification Scale
– The Calgary Depression Scale
Needs and strengths
– The Camberwell Assessment of Needs
– Client Assessment of Strengths, Interests, and Goals
Skills and deficits
– Micro-Modules Learning Tests
– Social Functioning Scale
– Work Behavior Inventory
– Recovery Assessment Scale
Specific mediators and moderators
– Social Engagement Scale
– Self-Esteem Rating Scale- Short-Form
– Drug/Alcohol Time Line Follow-Back Calendar
– MacArthur-Maudsley Delusions Assessment Schedule
– Belief About Voices Questionnaire-Revised
– The Working Alliance Inventory
– Satisfaction with Life Domains
Conclusions

People also search for Pharmacological and Psychosocial Treatments in Schizophrenia 3rd:

the psychosocial model of pain and non pharmacological treatments
    
types of psychosocial therapy
    
what are psychosocial treatments
    
psychosocial therapy examples
    
what is psychosocial therapy

Tags: David Castle, David L Copolov, Til Wykes, Kim T Mueser, Pharmacological, Psychosocial